Ascletis Pharma Inc. (HKG:1672)
13.65
+0.44 (3.33%)
At close: Dec 5, 2025
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of 13.54 billion as of December 5, 2025. Its market cap has increased by 823.15% in one year.
Market Cap
13.54B
Enterprise Value
11.57B
Revenue
2.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.65
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 15.69B to 13.54B, a decrease of -13.70%. That is a compound annual growth rate of -1.98%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.02B |
| Hansoh Pharmaceutical Group Company | 244.94B |
| JD Health International | 192.57B |
| Innovent Biologics | 160.32B |
| WuXi Biologics | 135.64B |
| Sino Biopharmaceutical | 122.99B |
| Akeso | 113.67B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.70B |